Vol 3, No 2 (2018)
Review paper
Published online: 2018-09-28

open access

Page views 2079
Article views/downloads 783
Get Citation

Connect on Social Media

Connect on Social Media

Acute coronary syndromes in the practice of the emergency medical team

Dominika Telecka-Gądek1, Marcin Madziała2, Łukasz Szarpak2, Sandra Pyda3
Disaster Emerg Med J 2018;3(2):61-66.

Abstract

An acute coronary syndrome (ACS) is described when myocardial ischemia occurs due to impeding blood flow through the coronary vessels, which in turn results in insufficient supply of oxygen. As a disease entity, it causes almost half of all deaths in Poland. The high mortality of ACS is primarily in the pre-hospital setting. The classification of acute coronary syndromes is based on criteria such as clinical symptoms, the nature and type of changes in the electrocardiogram, and indicators of myocardial necrosis. In the conditions of the emergency medical team, the division is based on the image of the ECG test. On this basis, ACS with elevation of the ST segment (STEMI) and without ST segment elevation (NSTEMI) are defined. Pre-hospital diagnosis of ACS includes an interview with the patient and a 12-lead ECG performed preferably in no more than 10 minutes since the first medical contact. The task of the emergency medical team is to quickly recognize, perform teletransmission to the interventional cardiology centre and implement pharmacological treatment, and then provide transport to the nearest centre of invasive cardiology, where the procedure should be performed to clear the blocked coronary artery. Therefore, it is important that the staff of medical emergency teams have appropriate knowledge and proper equipment for ambulances.

Article available in PDF format

View PDF Download PDF file

References

  1. Bonaca MP, Bhatt DL, Cohen M, et al. PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015; 372(19): 1791–1800.
  2. Bonaca MP, Bhatt DL, Cohen M, et al. PEGASUS-TIMI 54 Steering Committee and Investigators. Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015; 372(19): 1791–1800.
  3. Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016; 37(42): 3232–3245.
  4. Zgony według wybranych przyczyn. [w:] Rocznik demograficzny 2017. Główny Urząd Statystyczny, Zakład Wydawnictw Statystycznych, Warszawa 2017: 317.
  5. Kubica J, Adamski P, Paciorek P, et al. Leczenie antyagregacyjne u pacjentów z ostrym zespołem wieńcowym — zalecenia dla zespołów ratownictwa medycznego. Stanowisko ekspertów. Kardiol Pol. 2017; 75, supl. V: 47–56.
  6. Chmielewski M, Janiszewski M, Mamcarz A, et al. Ostre zespły wieńcwe. Oficyna Wydawnicza Medical Educatin sp. z o.o. Warszawa 2010.
  7. Sosada K. Ostre stany zagrożenia życia w chorobach wewnętrznych. Sosada K (red.). PZWL. Warszawa 2016.
  8. Budaj A, Beresewicz A, et al. Choroba niedokrwienna serca. [w:] Interna Szczeklika. Gajewski P. (red.). Medycyna Praktyczna. Kraków 2016: 168–595.
  9. Thygesen K, Alpert JS, Jaffe AS, et al. Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J. 2012; 33(20): 2551–2567.
  10. Thejanandan Reddy CS, Rajasekhar D, Vanajakshamma V. Electrocardiographic localization of infarct related coronary artery in acute ST elevation myocardial infarction. Journal of Clinical and Scientific Research. 2013: 151–160.
  11. Thygesen K, Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation. 2012; 126(16): 2020–2035.
  12. Nikolaou NI, Arntz HR, Bellou A, et al. Initial management of acute coronary syndromes section Collaborator. European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes. Resuscitation. 2015; 95: 264–277.
  13. Klabunde RE. Cardiac electrophysiology: normal and ischemic ionic currents and the ECG. Adv Physiol Educ. 2017; 41(1): 29–37.
  14. Janiszewski M, Kuch M. Pierwsze kroki diagnostyczne i terapeutyczne przy podejrzeniu ostrego zespołu wieńcowego, Medycyna po dyplomie. Medical Tribune Polska. 2018; 5.
  15. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. European Heart Journal. 2015; 37(3): 267–315.
  16. Smith JN, Negrelli JM, Manek MB, et al. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015; 28(2): 283–293.
  17. Giugliano RP, Braunwald E. The year in acute coronary syndrome. J Am Coll Cardiol. 2014; 63(3): 201–214.
  18. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction. The Lancet. 1995; 345(8951): 669–685.
  19. Welsh RC. Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial. Heart. 2005; 91(11): 1400–1406.
  20. de Bliek EC. ST elevation: Differential diagnosis and caveats. A comprehensive review to help distinguish ST elevation myocardial infarction from nonischemic etiologies of ST elevation. Turk J Emerg Med. 2018; 18(1): 1–10.
  21. Kleinrok A, Placzkiewicz DT, Puzniak M, et al. Electrocardiogram teletransmission and teleconsultation: essential elements of the organisation of medical care for patients with ST segment elevation myocardial infarction: a single centre experience. Kardiol Pol. 2014; 72(4): 345–354.
  22. Giugliano RP, Braunwald E. The year in acute coronary syndrome. J Am Coll Cardiol. 2014; 63(3): 201–214.
  23. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Kardiol Pol. 2018; 76(2): 229–313.